Literature DB >> 7462409

Epidemiological usefulness of changes in hemolytic activity of Vibrio cholerae biotype El Tor during the seventh pandemic.

T J Barrett, P A Blake.   

Abstract

Hemolytic Vibrio cholerae biotype El Tor strains were isolated in the United States in 1973 and 1978 after they had supposedly disappeared worldwide during the 1960s and 1970s. We decided to examine the change in prevalence of hemolytic El Tor strains since the beginning of the seventh pandemic and evaluate the usefulness of hemolytic activity as an epidemiological marker. A total of 48 isolates of V. cholerae biotype El Tor isolated in the Eastern Hemisphere between 1960 and 1979, along with 1 Texas (1973) and 38 Louisiana (1978) isolates, were tested for hemolytic activity by each of four methods. One method (utilizing heart infusion broth with 1% glycerol) was slightly superior for detecting hemolytic activity. Titers obtained with this method ranged from less than 2 to 1,024. Of 13 (76.9%) strains from the earliest part of the current pandemic, 10 were hemolytic, compared with 1 of 26 (3.8%) strains isolated in the period from 1966 to 1979 in the Eastern Hemisphere, indicating that nonhemolytic El Tor strains have replaced the hemolytic variety there. In contrast, all 38 Louisiana isolates and the Texas isolate were strongly hemolytic. Hemolytic activity was concluded to be a useful epidemiological marker.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7462409      PMCID: PMC273735          DOI: 10.1128/jcm.13.1.126-129.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  A NON-HAEMOLYTIC EL TOR VIBRIO AS THE CAUSE OF AN OUTBREAK OF PARACHOLERA IN WEST NEW GUINEA. THE EL TOR PROBLEM AND PANDEMIC PARACHOLERA IN THE WEST PACIFIC.

Authors:  C E DE MOOR
Journal:  Trop Geogr Med       Date:  1963-06

2.  OBSERVATIONS ON THE EL TOR VIBRIOS ISOLATED FROM CASES OF CHOLERA IN CALCUTTA.

Authors:  D BARUA; A C MUKHERJEE
Journal:  Bull Calcutta Sch Trop Med       Date:  1964-10

3.  Studies on the haemolytic activity of El Tor vibrios.

Authors:  J C FEELEY; M PITTMAN
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

4.  A new method for the differentiation of Vibrio comma and Vibrio El Tor.

Authors:  G K HAN; T S KHIE
Journal:  Am J Hyg       Date:  1963-03

5.  Preselection of hemolytic variants of el tor vibrios.

Authors:  R A Finkelstein
Journal:  J Bacteriol       Date:  1966-08       Impact factor: 3.490

6.  Induction of steroidogenesis in tissue culture by cholera enterotoxin.

Authors:  S T Donta; M King; K Sloper
Journal:  Nat New Biol       Date:  1973-06-20

7.  A case of cholera in Texas, 1973.

Authors:  J B Weissman; W E DeWitt; J Thompson; C N Muchnick; B L Portnoy; J C Feeley; E J Gangarosa
Journal:  Am J Epidemiol       Date:  1974-12       Impact factor: 4.897

8.  A note on designating strains as Vibrio cholerae biotype el tor.

Authors:  R Sen; D L Shrivastava
Journal:  Indian J Med Res       Date:  1970-02       Impact factor: 2.375

9.  Use of Moore swabs for isolating Vibrio cholerae from sewage.

Authors:  T J Barrett; P A Blake; G K Morris; N D Puhr; H B Bradford; J G Wells
Journal:  J Clin Microbiol       Date:  1980-04       Impact factor: 5.948

10.  Cholera--a possible endemic focus in the United States.

Authors:  P A Blake; D T Allegra; J D Snyder; T J Barrett; L McFarland; C T Caraway; J C Feeley; J P Craig; J V Lee; N D Puhr; R A Feldman
Journal:  N Engl J Med       Date:  1980-02-07       Impact factor: 91.245

View more
  26 in total

1.  Genomic relatedness of the new Matlab variants of Vibrio cholerae O1 to the classical and El Tor biotypes as determined by pulsed-field gel electrophoresis.

Authors:  Ashrafus Safa; Nurul Amin Bhuiyan; Munirul Alam; David A Sack; G Balakrish Nair
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

2.  Phenotypic and genotypic changes in Vibrio cholerae O139 Bengal.

Authors:  M J Albert; N A Bhuiyan; K A Talukder; A S Faruque; S Nahar; S M Faruque; M Ansaruzzaman; M Rahman
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

3.  Genetic diversity among toxigenic and nontoxigenic Vibrio cholerae O1 isolated from the Western Hemisphere.

Authors:  F Chen; G M Evins; W L Cook; R Almeida; N Hargrett-Bean; K Wachsmuth
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

4.  The El Tor biotype of Vibrio cholerae exhibits a growth advantage in the stationary phase in mixed cultures with the classical biotype.

Authors:  Subhra Pradhan; Amit K Baidya; Amalendu Ghosh; Kalidas Paul; Rukhsana Chowdhury
Journal:  J Bacteriol       Date:  2009-12-18       Impact factor: 3.490

5.  Vibrio cholerae serogroup O1 in northeast Thailand.

Authors:  T Kuyyakanond; S Nakamura; W Manmontri; M Iwanaga
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

6.  Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates.

Authors:  D V Singh; M H Matte; G R Matte; S Jiang; F Sabeena; B N Shukla; S C Sanyal; A Huq; R R Colwell
Journal:  Appl Environ Microbiol       Date:  2001-02       Impact factor: 4.792

7.  2,3-butanediol synthesis and the emergence of the Vibrio cholerae El Tor biotype.

Authors:  Sang Sun Yoon; John J Mekalanos
Journal:  Infect Immun       Date:  2006-10-02       Impact factor: 3.441

Review 8.  Navigating Microbiological Food Safety in the Era of Whole-Genome Sequencing.

Authors:  J Ronholm; Neda Nasheri; Nicholas Petronella; Franco Pagotto
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

Review 9.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

10.  Epidemiologic application of a standardized ribotype scheme for Vibrio cholerae O1.

Authors:  T Popovic; C Bopp; O Olsvik; K Wachsmuth
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.